The outlook of companies tied to the drug's past presents a complex investment landscape. While the initial boom generated substantial gains, generic copies have significantly diminished revenue. Investing https://bookmarkingquest.com/story21552598/copyright-s-flagship-product-and-big-pharma-a-uncertain-investment